Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Dexmedetomidine infusion on oxidative stress and DNA damage by Isoflurane exposure in surgery
TCTR20211230001Phase 0Completed
- Sponsor
- University of Veterinary and Animal Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of dexmedetomidine in oxidative stress and DNA damage, sponsored by University of Veterinary and Animal Sciences. Primary endpoints: Oxidative stress markers and DNA damage markers. Started Sep 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
oxidative stressDNA damage
Beyond the preview
Go deeper on TCTR20211230001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211230001.